Eli Lilly Company
-
{
- All
- News
-
On Camera, Trump's Drug Event Paused As Man Faints At White House
- Friday November 7, 2025
- World News | Edited by Sanstuti Nath
President Donald Trump had a jump scare at the White House when a man collapsed while standing just behind him during an event in the Oval Office.
-
www.ndtv.com
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
- Thursday March 20, 2025
- India News | Press Trust of India
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
www.ndtv.com
-
Weight-Loss Drugs Under EU Scanner Amid Suicide Risk Claims
- Saturday December 2, 2023
- World News | Deirdre Hipwell, Bloomberg
The European Union's drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co. for more information as it reviews the potential risk of suicidal thoughts associated with a new class of weight-loss medicines.
-
www.ndtv.com
-
Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
- Monday May 10, 2021
- India News | Reuters
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.
-
www.ndtv.com
-
US Pharma Firm Lilly Pauses COVID Antibody Treatment Trial Over Safety Concern
- Wednesday October 14, 2020
- World News | Agence France-Presse
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
-
www.ndtv.com
-
Eli Lilly Says Its Antibody Therapy May Reduce Covid Hospitalisations
- Thursday September 17, 2020
- World News | Riley Griffin and Cristin Flanagan, Bloomberg
Eli Lilly and Co.'s experimental antibody treatment for Covid-19 reduced the rate at which symptomatic patients were hospitalized compared to a placebo, according to preliminary study results released by the company and its partner.
-
www.ndtv.com
-
Government's Plan To Pull In 324 Companies Including Tesla, Glaxo: Report
- Wednesday November 20, 2019
- India News | Shruti Srivastava, Bloomberg
The government is planning to offer 324 companies including Tesla Inc. and GlaxoSmithKline Plc incentives to set up factories in India in a bid to capitalize from the trade war between China and the US., according to a document seen by Bloomberg.
-
www.ndtv.com
-
On Camera, Trump's Drug Event Paused As Man Faints At White House
- Friday November 7, 2025
- World News | Edited by Sanstuti Nath
President Donald Trump had a jump scare at the White House when a man collapsed while standing just behind him during an event in the Oval Office.
-
www.ndtv.com
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
- Thursday March 20, 2025
- India News | Press Trust of India
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
www.ndtv.com
-
Weight-Loss Drugs Under EU Scanner Amid Suicide Risk Claims
- Saturday December 2, 2023
- World News | Deirdre Hipwell, Bloomberg
The European Union's drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co. for more information as it reviews the potential risk of suicidal thoughts associated with a new class of weight-loss medicines.
-
www.ndtv.com
-
Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
- Monday May 10, 2021
- India News | Reuters
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.
-
www.ndtv.com
-
US Pharma Firm Lilly Pauses COVID Antibody Treatment Trial Over Safety Concern
- Wednesday October 14, 2020
- World News | Agence France-Presse
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
-
www.ndtv.com
-
Eli Lilly Says Its Antibody Therapy May Reduce Covid Hospitalisations
- Thursday September 17, 2020
- World News | Riley Griffin and Cristin Flanagan, Bloomberg
Eli Lilly and Co.'s experimental antibody treatment for Covid-19 reduced the rate at which symptomatic patients were hospitalized compared to a placebo, according to preliminary study results released by the company and its partner.
-
www.ndtv.com
-
Government's Plan To Pull In 324 Companies Including Tesla, Glaxo: Report
- Wednesday November 20, 2019
- India News | Shruti Srivastava, Bloomberg
The government is planning to offer 324 companies including Tesla Inc. and GlaxoSmithKline Plc incentives to set up factories in India in a bid to capitalize from the trade war between China and the US., according to a document seen by Bloomberg.
-
www.ndtv.com